Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copper(i) Acetate
2. Copper(ii) Acetate
3. Copper(ii) Acetate Monohydrate
4. Cu(ii) Acetate
5. Hoganite
1. Copper(ii) Acetate
2. 142-71-2
3. Copper Diacetate
4. Copper Acetate
5. Copper(ii)acetate
6. Copper(2+) Acetate
7. Copper(2+) Diacetate
8. Copper (ii) Acetate
9. Cupric Diacetate
10. Neutral Verdigris
11. Crystals Of Venus
12. Acetic Acid, Copper(2+) Salt
13. Copper Acetate (cu(c2h3o2)2)
14. Crystallized Verdigris
15. Acetic Acid, Copper(2+) Salt, Basic
16. Cupric Acetate,anhydrous
17. Copper Acetate (cu(oac)2)
18. Acetic Acid Copper(2+) Salt
19. 39m11xph03
20. Acetic Acid, Copper(ii) Salt (2:1)
21. 52503-64-7
22. Copper Di(acetate)
23. Acetic Acid, Copper(2+) Salt (2:1)
24. Venus Copper
25. Copper(ii)-acetate
26. Acetic Acid, Copper Salt
27. Octan Mednaty [czech]
28. Octan Mednaty
29. Acetic Acid, Cupric Salt
30. Mfcd00008690
31. Acetate De Cuivre
32. Acetate De Cuivre [french]
33. Cu(ii) Acetate
34. Ccris 5286
35. Hsdb 915
36. Cupric Acetate, Basic
37. Nsc-75796
38. 4180-12-5
39. Einecs 205-553-3
40. Nsc 75796
41. Diacetoxycopper
42. Bisacetoxycopper
43. Unii-39m11xph03
44. Copper;diacetate
45. Diacetoxy Copper
46. Ai3-01379
47. Acetic Acid, Copper (2+) Salt
48. Copper Acetate Salt
49. Copper(ii)diacetate
50. Copper (ii)acetate
51. Copper-(ii)acetate
52. Einecs 257-974-7
53. Copper(1i) Acetate
54. Copper(11) Acetate
55. Copper(ii) Diacetate
56. Copper-(ii) Acetate
57. Copper-(ii)-acetate
58. Cuprum Aceticum
59. Copper (ii) Diacetate
60. Diacetoxy Copper (ii)
61. Acetic Acid,copper Salt
62. Cu(oac)2
63. Ec 205-553-3
64. Schembl1080
65. Cupric Acetate [mi]
66. Acetic Acid Copper(ii) Salt
67. Copper,bis(acetato-ko,ko')-
68. Cupric Acetate [inci]
69. Cuprum Aceticum [hpus]
70. Copper Acetate [mart.]
71. Copper Acetate [who-dd]
72. Dtxsid2059720
73. Copper(ii) Acetate [hsdb]
74. Copper(ii) Acetate, Anhydrous
75. Akos015892699
76. Copper(ii) Acetate, Trace Metals Grade
77. Ft-0653868
78. D77909
79. Q421854
80. J-520114
| Molecular Weight | 181.63 g/mol |
|---|---|
| Molecular Formula | C4H6CuO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 180.956206 g/mol |
| Monoisotopic Mass | 180.956206 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 25.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Medication (VET): In hematinic mixtures (liquid or tablets) as source of copper.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 132
There are limited data concerning toxicity of copper in experimental animals. Heavy accumulation of copper was observed in the liver and kidneys of rats maintained for 16 mo on a diet supplemented with 5,000 ppm copper acetate. Similar depositions were seen in the liver and kidney as well as the brain and the large and small bowel in rats exposed to 1250 ppm cupric acetate monohydrate in the drinking water for up to 902 days.
USEPA; Health Issue Assessment: Copper p.33 (1987) EPA/600/8-87/001
The effects of cadmium and copper on the sodium ion (Na(+)) glucose cotransport in the kidney cortical cells of 4 week old male C57B16-rats were studied. Different concentrations of cadmium chloride, zinc chloride, or cupric acetate were added to the culture media. The Na(+)-glucose cotransport was estimated from the uptake of radiolabeled alpha-methylglucoside using scintillation counting techniques. Metallothionein was measured by Sephadex-G-75 column chromatography and subsequent high performance liquid chromatography. For Cd(2+) and Cu(2+), an increase in concentration resulted in an increase in the extent of inhibition of the Na(+)-glucose cotransport with approximately 3 hour lag times for the induction of inhibition. Increases in metal ion concentration also resulted in slower increases of metallothionein protein, with the rapid induction of metallothionein messenger RNA after incubation with the ions. Pretreatment of the cells with zinc(2+) reduced the effects of Cd(2+) and Cu(2+) on the cotransport by delaying the onset and reducing the extent of the inhibition.
PMID:7992308 Blumenthal S et al; Toxicology and Applied Pharmacology 129 (2): 177-87 (1994)
Ascorbic acid incubation reduced the occurrence of copper acetate induced increases in methemoglobin, while not effecting changes in glutathione in rats.
PMID:6635265 Calabrese EJ et al; Regul Toxicol Pharmacol 3 (3): 179-83 (1983)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Cupric acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cupric acetate, including repackagers and relabelers. The FDA regulates Cupric acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cupric acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cupric acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cupric acetate supplier is an individual or a company that provides Cupric acetate active pharmaceutical ingredient (API) or Cupric acetate finished formulations upon request. The Cupric acetate suppliers may include Cupric acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Cupric acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cupric acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cupric acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cupric acetate GMP manufacturer or Cupric acetate GMP API supplier for your needs.
A Cupric acetate CoA (Certificate of Analysis) is a formal document that attests to Cupric acetate's compliance with Cupric acetate specifications and serves as a tool for batch-level quality control.
Cupric acetate CoA mostly includes findings from lab analyses of a specific batch. For each Cupric acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cupric acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cupric acetate EP), Cupric acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cupric acetate USP).
LOOKING FOR A SUPPLIER?
